Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

In Brief: Perkin-Elmer/Hyseq

This article was originally published in The Gray Sheet

Executive Summary

Perkin-Elmer/Hyseq: Firms ink strategic partnership agreement to commercialize DNA microchip technology which includes a $10 mil. equity investment in Hyseq by Perkin-Elmer, P-E announces June 19. Under the terms of the deal, both firms will invest additional research funds in Hyseq's proprietary DNA HyChip technology. Combination of the HyChip technology with P-E DNA analysis technologies is anticipated to enable creation of a DNA chip "that can assay any genetic target through the use of specially designed reagents and software," P-E says. P-E will have exclusive worldwide rights to commercialize sequencing systems using the HyChip technology under the agreement...
Advertisement
Advertisement
UsernamePublicRestriction

Register

MT008278

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel